Wilson Sonsini Goodrich & Rosati advised Harpoon Therapeutics on the deal, while Latham & Watkins LLP represented the underwriters. Harpoon Therapeutics, Inc. announced the pricing of…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
